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ABSTRACT
The excision of mutagenic DNA adducts by the nu-
cleotide excision repair (NER) pathway is essential
for genome stability, which is key to avoiding genetic
diseases, premature aging, cancer and neurologic
disorders. Due to the need to process an extraordi-
narily high damage density embedded in the nucleo-
some landscape of chromatin, NER activity provides
a unique functional caliper to understand how his-
tone modifiers modulate DNA damage responses. At
least three distinct lysine methyltransferases (KMTs)
targeting histones have been shown to facilitate the
detection of ultraviolet (UV) light-induced DNA le-
sions in the difficult to access DNA wrapped around
histones in nucleosomes. By methylating core his-
tones, these KMTs generate docking sites for DNA
damage recognition factors before the chromatin
structure is ultimately relaxed and the offending le-
sions are effectively excised. In view of their function
in priming nucleosomes for DNA repair, mutations of
genes coding for these KMTs are expected to cause
the accumulation of DNA damage promoting cancer
and other chronic diseases. Research on the ques-
tion of how KMTs modulate DNA repair might pave
the way to the development of pharmacologic agents
for novel therapeutic strategies.
INTRODUCTION
Genome stability is constantly threatened by endogenous
and exogenous DNA-damaging agents that induce a vari-
ety of DNA base or backbone lesions. A network of DNA
repair processes avoids the conversion of DNA damage to
mutations and chromosomal aberrations, thus preventing
genetic diseases, premature aging, cancer and other chronic
conditions (1–3). Nucleotide excision repair (NER) is the
DNA repair process dedicated to the removal of DNA
adducts that are typically larger than normal nucleotides.
Prominent examples of such bulky lesions, arising at high
frequency in the genome, are di-pyrimidine crosslinks in-
duced by ultraviolet (UV) light and DNA adducts gener-
ated by chemical carcinogens. In particular, UV radiation is
the most common environmental genotoxic agent and the
major etiological factor for the development of skin cancer.
Depending on the locality, season, time of day, weather con-
ditions and the period of exposure, an assault by the short-
wave sunlight spectrum generates in each skin cell hun-
dreds of thousands of covalent crosslinks between neigh-
boring pyrimidines, predominantly cyclobutane pyrimidine
dimers (CPDs) and pyrimidine–pyrimidone (6-4) photo-
products (6–4PPs) in a stoichiometry of ∼4:1 (4–6). The
multipronged cellular responses to this genotoxic insult can
only be understood through analyses in the physiologic con-
text of the tightly packed chromatin substrate.
DISTRIBUTION OF DNA DAMAGE IN CHROMATIN
A compaction of DNA in the nuclei of eukaryotic cells is
imposed by the need to package the genome (consisting of
∼6.4 × 109 bp in a diploid human cell) into its tight nuclear
compartment. To remain accessible for genomic functions,
DNA filaments are assembled with histones to form a con-
densed but highly adjustable supramolecular array whose
repeating unit is the nucleosome. Each nucleosome repeat
comprises a core particle consisting of 147 bp of the DNA
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helix wrapped∼1.7 times around a histoneH3–H4 tetramer
flanked by two H2A–H2B dimers. These core particles are
intrinsically stable due to the many electrostatic contacts
between the negatively charged DNA backbone and posi-
tively charged residues of the basic histones. Linker DNA
of variable length (20–50 bp) connects core particles and,
in higher eukaryotes, histone H1 induces additional com-
paction (7–9). This ‘chromatinization’ with ∼30 million nu-
cleosomes per diploid human genome does not generally
avert genotoxic reactions, although it modulates their in-
cidence, but restricts the accessibility for subsequent DNA
repair reactions. As an example, the induction of CPDs
and resultingmutations aremodulated by transcription fac-
tors and histones (10,11). Throughout chromatin, however,
these lesions occur rather uniformly (12–14). There is only a
small (maximally twofold) bias for CPD formation in linker
DNAwith the consequence that most UV lesions in a dam-
aged genome are found inside the 147 bp of nucleosome
cores (14–16). HowNER factors detect DNA lesions in this
‘chromatinized’ substrate is a long-standing question that
has been the focus of intense research. Repair assays in re-
constituted cell-free systems indicated that the assembly of
DNA into nucleosomes is, in principle, inhibitory to UV le-
sion excision (17–20). However, UV damage repair is effi-
cient in intact living cells, implying that chromatin is tem-
porarily rearranged to allow for NER activity (21,22).
THE ACCESS–REPAIR–RESTORE MODEL FOR NER
ACTIVITY IN CHROMATIN
The cut-and-patch NER reaction has been elucidated in de-
tail (23–25), but the mechanism allowing for bulky lesion
recognition in the chromatin context remains to be under-
stood. Because DNA damage in chromatin is refractory to
repair, NER activity requires that nucleosomes are mobi-
lized by ATP-dependent chromatin remodelers and post-
translational histone modifications (21,26–28). A power-
ful tool for the spatiotemporal analysis of chromatin re-
arrangements came from DNA dissection by micrococcal
nuclease (MNase). This enzyme digests DNA more eas-
ily in the accessible linker segments than that in histone-
assembled nucleosome cores. Therefore, MNase generates
a soluble supernatant containing proteins that, before di-
gestion, were associated with linker DNA as well as a mi-
nor fraction of isolated core particles referred to as ‘mono-
nucleosomes’. Even at saturating enzyme levels, thisMNase
digestion leaves behind the vast majority of core parti-
cles (containing DNA fragments of 147 bp) in the form
of a densely packed and insoluble nucleoprotein fraction
(29). In a pioneering experiment, this enzyme was used to
monitor the fate of excision repair patches in UV-exposed
fibroblasts. The cells were pulse-labeled with radioactive
thymidine immediately after irradiation and, then, chased
in non-radioactive medium for different times. Smerdon
and Liebermann (30) observed that, initially, most of the
incorporated radioactivity reflecting repair synthesis oc-
curs in MNase-sensitive chromatin although, with increas-
ing chase time, this radioactivity becomes progressively
nuclease-resistant. This finding implies that DNA repair
patches are not synthesized within nucleosomes but, in-
stead, are subjected to nucleosome packaging after com-
pletion of the repair reaction. Such rearrangements involv-
ing chromatin disassembly and reassembly have later been
confirmed by genome-wide analyses of nucleosome occu-
pancy, based on high-resolutionmapping byDNA sequenc-
ing (31), and gave rise to the ‘access, repair, restore’ model to
account for the efficient excision of CPDs formed in nucleo-
some cores (27,28). It is not yet clear if chromatin rearrange-
ments during UV lesion repair involve nucleosome sliding,
destabilization or disruption (32). In any case, DNA repair
synthesis is accompanied by chromatin restoration through
nucleosome repositioning mediated by histone chaperones
(33,34). Histones are escorted during DNA repair synthesis
by the chaperone CAF-1 (Chromatin Assembly Factor-1),
whose largest subunit interacts with the DNA polymerase
sliding clamp PCNA (Proliferating Cell Nuclear Antigen)
(35–37). CAF-1 interacts with another histone chaperone
known asASF1 (Anti-Silencing Function 1) (38) that serves
as the histone donor (39). This chromatin restoration pro-
cess also involves the deposition of the histone variants
H2.X and H3.3 by the histone chaperones FACT (FAcili-
tates Chromatin Transcription) and HIRA (HIstone Regu-
lator A), respectively (40–42).
DOES CHROMATIN STABILIZATION PRECEDE
DESTABILIZATION?
The ‘access-repair-restore’ model, outlined above, proposes
that the chromatin structure must be disrupted or at least
weakened to expose damaged sites to DNA repair factors.
This model raises the fundamental question of whether
chromatin relaxation precedes lesion detection or vice versa.
A possible solution to this conundrum is that chromatin
should, perhaps, not be considered as an absolute barrier to
repair processes in a way that nucleosomes need to be dis-
solved for the initial access of recognition factors to DNA
lesions. Instead, several counterintuitive findings lend sup-
port to the view that chromatin may have a scaffolding role
to facilitate DNA damage recognition.
One important notion is that the pattern of inflicted dam-
age follows the bending of DNA around the surface of the
histone octamer in a way that nucleosomesmodulateUV le-
sion formation by favoring the more accessible outside fac-
ing sites and disfavoring less accessible inward sites in the
proximity to histones (43,44). A more intriguing observa-
tion is that heterochromatin protein 1 (HP1) family mem-
bers are recruited to various DNA damages, including UV
lesions, independently of DNA repair (45). Proteins of the
HP1 family (HP1, HP1, HP1 ) localize to contracted
heterochromatin regions like centromeres and telomers, but
rapidly switch between free and chromatin-bound states
(46). The loss of HP1 isoforms is lethal in mammalian
cells, but a function of these chromatin-condensing factors
in the DNA damage response has been demonstrated in
Caenorhabditis elegans, as mutant nematodes missing the
two C. elegans isoforms HPL-1 and HPL-2 are highly UV
radiation-sensitive (45). Another surprising observation is
that an accumulation of the aforementioned histone chaper-
one HIRA at UV-damaged sites takes place already during
early NER steps before incision/excision/repair synthesis
and, in fact, this HIRA recruitment depends on the cullin
4-RING ubiquitin ligase (CRL4) activity that accompa-
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nies the initial lesion recognition (see below). The transient
HIRA enrichment in damaged chromatin is followed by an
increased deposition of the histone H3.3 variant before ex-
ecution of the NER reaction (47). Notably, the function of
HP1 and HIRA in the DNA damage response is not lim-
ited to theUV response but extends to other types of lesions
including DNA double strand breaks (DSBs) (47,48). An-
other unexpected finding came from chromatin immuno-
precipitation (ChIP) experiments using XPC protein as the
bait. The precipitated nucleoprotein complexes contain his-
tone H3, unmodified and trimethylated at position lysine
9 (H3K9me3), but are essentially devoid of some acety-
lated forms of histone H3. Similarly, the induction of UV
lesions in the nuclei of human cells, by irradiation through
5 m-wide pores, generated subnuclear spots of UV dam-
age that are depleted of acetylated histone H3 (49). These
observations are surprising because acetylation is a post-
translational histone modification that increases the acces-
sibility of DNA-binding factors and, in fact, the presence of
acetylated histones correlates with the relaxed chromatin of
transcribed genes (50). These findings indicate that histones
are transiently deacetylated in response to UV damage and,
consequently, that NER activity is not regulated in the same
way as transcription.
Taken together, these reports describing the recruitment
of HP1 and HIRA, the latter promoting histone deposi-
tion, as well as the loss of histone acetylation in response
to UV damage, suggest that the immediate DNA damage
response involves a stabilization of the nucleosome struc-
ture. This conclusion is supported by studies with cells of
the silkworm Bombyx mori, revealing that polycomb re-
pressing complexes (PRCs), which lead to chromatin com-
paction, also participate in the UV response (51). Why do
proteins that promote a condensed chromatin state accom-
pany early NER reactions? A possible explanation is that a
transient chromatin contraction upon DNA insults serves
to block transcription and avoid molecular collisions be-
tween RNA polymerases and repair enzymes (52). In keep-
ing with this hypothesis, another report showed that, dur-
ing DSB repair, transcription is switched off by recruiting
PRC1 via ATM-mediated phosphorylation (53). In the case
of UV lesions, however, we favor the alternative explana-
tion that safeguarding the stability of nucleosomes around
injured sites is critical forDNAdamage recognition and ini-
tiation of NER activity. This mechanism may counteract
the nucleosome-destabilizing effect of DNA damage, thus
avoiding a premature histone eviction in view that, for ex-
ample, a single CPD lesion is sufficient to induce unwrap-
ping of the nucleosome core (54,55). We propose that nucle-
osome arrays provide an indispensable scaffold for damage
recognition during NER activity and that, in this context,
certainKMTs introduce a histone code thatmakes this scaf-
fold more permissive to NER transactions.
MAMMALIAN CORE NER REACTION
Throughout evolution, the NER machine is the only avail-
able toolbox for the removal of bulky lesions. Its cut-and-
patch reaction course involves the excision of DNA adducts
by dual incision of damaged strands, followed by their re-
lease as part of 24- to 32-nucleotide long single-stranded
segments (56,57). This repair process is initiated by two al-
ternative recognition modes. In transcription-coupled re-
pair (TCR), damage excision is triggered by collision of the
elongating RNA polymerase II (RNA Pol II) with DNA
lesions and this roadblock prioritizes the excision of dam-
age located on transcribed strands. By backtracking of
the stalled RNA Pol II and promoting the repair of tran-
scribed strands, the TCR pathway allows for a rapid re-
covery of transcription to prevent apoptosis (58–60). In-
stead, the genome-wide NER activity, which includes the
repair of non-transcribed strands, is termed global-genome
repair (GGR) (3,61). This GGR pathway prevents replica-
tion forks from encountering DNA lesions, thus mitigat-
ing damage-induced mutagenesis. Genetic GGR defects re-
sult in xeroderma pigmentosum (XP), a cancer-prone syn-
drome presenting with photosensitivity, severe sunburns,
skin photoaging, ocular pathologies and, in the absence of
sunlight protection, a>1000-fold increased risk of skin can-
cer. GGR defects also confer a higher susceptibility to lung,
breast and colorectal cancer, and XP patients also suffer
from neurologic disorders (25,62–64).
Mechanistically, the GGR system uses a complex con-
sisting of XPC protein, one of two RAD23 homologs (pri-
marily RAD23B) and centrin 2 (CETN2) (65–68) to de-
tect bulky lesions anywhere in the genome (Figure 1). The
XPC subunit functions as a sensor of base pairs with re-
duced Watson–Crick stability compared to the native base
complementarity. This indirect recognition mode, by which
XPC detects unpaired but intact bases in the undamaged
strand, explains how the GGR reaction achieves a wide
substrate range despite the absence of a common chemi-
cal structure of the offending adducts (69–72). It has been
estimated that a human cell may contain between 25 000
(73) and 80 000 XPC molecules (74) such that, consid-
ering the size of the diploid human genome, each XPC
molecule would need to interrogate up to 250 000 bp.
Fluorescence-based protein dynamics studies showed that a
DNA-repulsive motif of XPC protein, favoring dissociation
of this DNA-binding subunit from native DNA, is impor-
tant to achieve the high mobility required for an effective
target search (67,75). In line with this observation, quan-
tumdot-based tracking experiments revealed that theXPC–
HR23B complex diffuses along the DNA helix by a ‘hop-
ping’ mechanism via repeated dissociation and nearby re-
association events (76). In this ‘hopping’ scenario of protein
movement, nucleosomes could be either an obstacle or pro-
vide a grip for XPC protein and, accordingly, histone mod-
ifiers are likely to play a crucial role for the target search.
Once bound to DNA lesion sites, RAD23B dissociates
and the remaining XPC-CETN2 dimer forms a landing
platform for the 10-subunit TFIIH (Transcription Factor
IIH) complex to allow for damage verification (77–79). This
recruitment ismediated by interactions ofXPCproteinwith
the p62 and XPB subunits of TFIIH together with the use
of the ATPase activity of XPB to anchor the complex onto
the DNA substrate (80–82). Subsequently, the TCR and
GGR reactions converge on a joint pathway where the re-
cruitment of XPA triggers the release of the CAK (CDK-
ActivatingKinase) sub-complex of TFIIH and launches the
XPD helicase subunit of TFIIH, which unwinds the dou-
ble helix and thereby scans the targeted DNA strand for
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Figure 1. GG-NER reaction in chromatin. This scheme summarizes the major transitions of the GGR reaction cycle (from DNA damage recognition
to the final DNA gap filling) and the ‘access-repair-restore’ model describing how this multistep process may take place in the nucleosome landscape
of chromatin. The XPC subunit initiates GGR activity as part of a trimeric complex with HR23B and CETN2. KMTs favor the GGR reaction in the
nucleosome context by constitutive and DNA damage-induced depositions of histone methylation marks.
abnormal chemical structures (83–86). The XPD-mediated
unwinding extends over ∼25 nucleotides (87,88) and gener-
ates a ‘bubble’ intermediate that is stabilized byRPA (Repli-
cation Protein A) together with XPA (89,90), and these
two factors assemble a DNA incision machinery. The dam-
aged strand is in that way cleaved at the double- to single-
stranded DNA junctions on each side of the ‘bubble’. A
heterodimer of XPF and ERCC1 (Excision Repair Cross-
Complementing 1) makes the 5′ cut, followed by incision on
the 3′ side through XPG (91). After this dual incision and
release of an oligonucleotide carrying the lesion, integrity
of the double helix is restored by DNA repair synthesis (92)
and ligation (73,93).
PYRIMIDINE DIMER COMPLEXITIES
The two major di-pyrimidine lesions induced by sunlight
differ with regard to structure and biological effects. First,
CPDs occur more abundant than 6–4PPs. Second CPDs
cause a minor thermodynamic destabilization of Watson–
Crick base pairs compared to 6–4PPs (94–96) such that,
without further assistance, the XPC initiator of GGR ac-
tivity would fail in their detection. Instead, XPC protein
is able to sense on its own the more pronounced base pair
destabilization caused by 6–4PPs (97,98). Third, there is as
mentioned before a rather uniform distribution of CPDs in
the genome, whereas 6–4PPs are found predominantly in
linkerDNA (43,99,100). Fourth, CPDs are excised at slower
rates than 6–4PPs and, consequently, are responsible for the
adverse UV radiation effects including sunburns, skin pho-
toaging and cutaneous cancer (101–103).
The detection of CPDs generally depends on an auxil-
iaryDNAdamage recognition complex known asUV-DDB
(UV-damagedDNA-binding; Figure 1). TheDDB2 subunit
of this heterodimer acts as a UV lesion receptor that inserts
itself like a wedge into the damaged double helix and inter-
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acts directly with the lesion by accommodating the pyrimi-
dine dimer into a shallow binding pocket (104–107). By con-
necting with its adaptor DDB1, this direct recognition of
UV lesions leads to the recruitment of the cullin 4A scaf-
fold and the RING finger protein ROC1, which build the
CRL4DDB2 ubiquitin ligase that modifies DDB2 itself, XPC
protein (108) and histones (109,110) with ubiquitin moi-
eties. K48-linked ubiquitin chains trigger the proteasomal
degradation of DDB2 after extraction from chromatin by
the ubiquitin-dependent p97 segregase (111,112) to allow
for follow-up GGR events (113–115). Ubiquitinated XPC
protein is also extracted by the p97 segregase, but with-
out degradation, and a further role of ubiquitin chains in
regulating the spatial protein distribution is discussed be-
low. It should be mentioned that XPC undergoes another
round of ubiquitination via the RNF111 ubiquitin ligase
(also known as Arkadia), which attaches K63-linked ubiq-
uitin chains (116,117). This extra ubiquitination byArkadia
is dependent on the prior modification of XPC protein with
SUMO (SmallUbiquitin-relatedMOdifier), which has been
implicated in promoting a rapid release of UV-DDB from
its association with the XPC complex (118). These modifi-
cations of DDB2 and XPC are, therefore, indispensable for
the well-timed substrate handover from one factor to the
next along theGGRpathway.With regard to histones, it has
been proposed that the CRL4DDB2-mediated ubiquitination
ofH2A,H3 andH4 in response toUV radiation helps open-
ing chromatin, thus facilitating access of downstreamGGR
players after the initial lesion detection (109,110,119). It is
also known that UV-DDB recruits chromatin remodelers
(26), the histone chaperoneHIRA (47), PARP1 [Poly(ADP-
Ribose)Polymerase 1] (120,121) and histone modifiers like
acetyltransferases (122–125), which may all contribute to
rearranging chromatin for CPD repair.
NUCLEOSOMES AS A SCAFFOLD FOR GGR INITIA-
TION
The predominant occurrence of CPDs within nucleosome
cores raises the question of whether the tight wrapping
of DNA around histones might render these lesions more
or less recognizable. Interestingly, the crystal structure of
a core particle containing CPD lesions revealed that, un-
like their nearly native Watson-Crick configuration in the
naked double helix, the two crosslinked pyrimidines do
not form regular hydrogen bonds, i.e. one pyrimidine is
displaced away from its complementary purine, indicating
thatWatson–Crick base pairing is substantially destabilized
(126). In view of this eye-catching feature of a base pair
destabilization provoked by coiling the DNA around his-
tone octamers, the CPD lesion might become more con-
ducive to recognition by both UV-DDB, the UV lesion re-
ceptor, and XPC protein, the GGR initiator. Such consid-
erations may have a broader relevance for carcinogen-DNA
adducts in general. In fact, molecular dynamics studies sug-
gest that histone tails might favor the base pair-disrupted
conformation induced by a cis-benzo[a]pyrene-dG adduct
positioned within a nucleosome core particle, perhaps fur-
ther exposing the flipped-out base to promote recognition
by XPC protein (127).
Irrespective of the detailed structural characteristics of
damaged nucleosomes, UV-DDB has been shown to asso-
ciate tightly with chromatin following UV irradiation (128)
and to remain bound to mono-nucleosomes when the chro-
matin of UV-irradiated cells is solubilized by MNase diges-
tion (129). That UV-DDB is able to detect CPDs in chro-
matin was demonstrated by reconstituting nucleosome core
particles with DNA fragments, containing a site-directed
CPD, and recombinant human core histones assembled
into octamers. Electrophoretic mobility shift assays (EM-
SAs) unequivocally demonstrated that UV-DDB binds to
the site-specific CPD even when this lesion is incorporated
into the reconstituted core particles (105). Cryo-electron
microscopy studies indicate that DDB2, the damage re-
ceptor subunit of UV-DDB, avoids clashes with histone
residues while binding to UV lesions in nucleosomes. In the
case of nucleosome-buried lesions that face the inside his-
tone core, UV-DDB shifts the position of DNA relative to
the histone octamer in a way that the lesion reaches a more
outward localization facing away from the histone core (32).
In contrast to these findings obtained with UV-DDB, in-
conclusive results were generated from studies carried out
to test the binding of XPC protein to nucleosomes. The
above described in vitro assembly of core particles, with a
site-directedUV lesion, suppressed the binding of the XPC-
HR23B complex to the lesion site as measured by EMSA
(130). Another report showed that XPC protein binds to
nucleosome core particles in vitro without dissociating the
histone-DNA complex, although only at high concentra-
tions and without being able to discriminate between dam-
aged and undamaged substrates (18). These findings could
be taken as evidence that XPC protein, on its own, is unable
to detect damaged DNA sites within nucleosome cores.
Protein dynamics studies based on fluorescent fusion
tags, combined with fluorescence recovery after local pho-
tobleaching in living cells, revealed a low nuclear mobil-
ity of XPC protein, indicating that this factor, in contrast
to other NER subunits, is constantly associated with chro-
matin fibers (131). Additionally, electronmicroscopy analy-
sis showed that the XPC complex occupies condensed chro-
matin regions whereas all the other NER factors are re-
cruited preferentially to UV lesions in less condensed chro-
matin regions (132). Accordingly, XPC protein also colo-
calizes with mitotic chromosomes (74,131). The presence of
XPCprotein in compacted chromatin has been attributed to
the affinity of this factor for DNA in general and the higher
DNA concentration in condensed chromatin. In view of the
long-held notion, derived from in vitro reconstitution ex-
periments (18,130), that nucleosomes pose a barrier to the
binding of XPC protein to the DNA substrate, it was very
surprising to find uponMNase digestion of chromatin that,
instead, a substantial fraction of XPC protein associates
with the nuclease-resistant fraction rich in core particles
(133). The proportion of XPC protein associated with core
particles even increases upon UV irradiation, suggesting
that, in intact cells, the XPC complex is able to detect UV le-
sion sites even when the damaged DNA is wrapped around
histones. Further chromatin fractionation experiments, car-
ried out under conditions that resulted in inhibition of
CRL4DDB2 activity, showed that the UV-DDB-dependent
ubiquitination of the XPC subunit serves to retain this fac-
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tor at MNase-sensitive sites, which are more amenable to
GGRactivity, against the default association of unmodified
XPC protein (devoid of ubiquitin) with MNase-resistant
core particles. Accordingly, in the absence of CRL4DDB2
activity, more XPC protein binds to lesions located in nu-
cleosome core particles (133). Later reports demonstrated
that XPC protein displays an intrinsic avidity for histones
(see below), suggesting that the apparent discrepancy be-
tween the findings obtained with the recombinant histones
of reconstituted nucleosome core particles (to which XPC
protein binds poorly) and the respective nucleoprotein com-
plexes extracted from cells (to which XPC protein binds
abundantly) may be explained by the existence of specific
post-translational histone modifications occurring in living
cells.
AFFINITY OF XPC PROTEIN FOR HISTONES
Immunoprecipitation studies confirmed that XPC protein
coexists in nucleoprotein complexes together with histones
H1, H3 and H4 (49,134). A direct interaction with histones
H1 and H3, extracted from human fibroblasts or from re-
combinant sources, was demonstrated in biochemical as-
says based on far-Western blots (49). Interestingly, XPC-
histone associations are dampened when this far-Western
assay was performed using hyper-acetylated histones ob-
tained from cells treated with the histone deacetylation in-
hibitor trichostatin A. Next, different truncated versions
of human XPC protein were subjected to the far-Western
assay, thus suggesting that amino acid residues at the N-
terminus constitute a possible domain for contacts with H1
and H3 (Figure 2). In parallel, pull-down assays with his-
tone H3 and truncated XPC protein indicated that another
histone-interacting domain may reside in the C-terminus.
Interestingly, the formation of XPC-histone complexes, de-
termined in pull-down assays, was weakened by H3 acety-
lation at positions lysine 14 and lysine 27 (49).
Interactions between XPC and histones were also evi-
denced after the release of core particles by MNase di-
gestion (134). This treatment generates soluble mono-
nucleosome core particles amenable to immunoprecipita-
tion using, for example, antibodies against histone H3.
Analysis of the composition of immunoprecipitated com-
plexes confirmed not only an increased appearance of
DDB2 followingUV radiation but also the presence ofXPC
protein. It remained possible that the interaction of XPC
protein with core particles is mediated by its association
with DNA. To rule out this, solubilized core particles were
digested by benzonase, revealing that the absence of DNA
around histone octamers does not reduce the amount of as-
sociatedXPC protein. On the contrary, the benzonase treat-
ment increased the interaction of XPC protein with the re-
maining DNA-free histone octamers.
To further test the hypothesis of a direct XPC–histone in-
teraction, recombinant XPC protein from insect cell lysates
was incubated with recombinant histones (the H3K4me3
form was used for these experiments instead of unmodi-
fied H3 due to the comparably higher efficiency of immuno-
precipitation with the respective antibody) (134). This pull-
down led to the co-isolation of XPC protein, thus lending
further support to a direct interaction between XPC pro-
tein and histones. A -turn motif (residues 741–757 of the
human XPC protein) does not make contacts with DNA
(71), but displays two negatively charged amino acids (posi-
tions 748 and 755) that may interact with positively charged
histone residues (Figure 2). The prediction that the affin-
ity for histones might be diminished by replacing nega-
tively charged amino acids with positively charged coun-
terparts was confirmed by expressing, in XP-C fibroblasts,
mutant XPC containing charge inversions. By immunopre-
cipitation, it was shown that the D748K mutation reduces
the ability of XPC protein to associate with histone H3.
These same XPC constructs were used to complement the
GGR defect of UV-irradiated XP-C fibroblasts, revealing
that the reduced histone binding of the D748Kmutant cor-
relates with impaired CPD repair. To confirm that the -
turn (residues 741–757) participates in histone binding, it
was shown that a polypeptide spanning XPC residues 607–
766 (including the -turn) but not the shorter polypeptide
607–741 (without the -turn) retained the capacity for his-
tone binding. Collectively, the studies of Kakumu et al. (49)
and Balbo Pogliano et al. (134) suggest that XPC protein
displays multiple interfaces for interactions with histones.
GGR TRANSACTIONS ON A ‘CHROMATINIZED’ SUB-
STRATE
The enzymatic GGR steps require that histones are tempo-
rary released from the DNA substrate by chromatin remod-
eling complexes, which use the energy of ATP hydrolysis
to eject, slide, reorganize or replace nucleosomes (19,135–
137). The DDB2 damage receptor, alone or in combina-
tion with theDDB1 adaptor, recruits at least two chromatin
remodelers, i.e. ALC1 (Amplified in Liver Cancer 1) (138)
and INO80 complex (INOsitol requiring 80) (139) to UV
lesion sites. In isolation, these reports on the contribution
of remodelers tend to suggest that nucleosomes need to be
quickly displaced before recruitment of XPC protein, which
serves as the initiator of GGR activity. However, there is
also evidence indicating that chromatin remodelers are in-
volved in downstreamGGR reactions taking place after the
association of XPC protein with damaged sites.
One example is provided by Rüthemann et al. (140),
who found that theCHD1 (ChromodomainHelicaseDNA-
binding 1) remodeler stimulates a substrate handover from
XPC to the TFIIH complex taking place explicitly on nucle-
osome core particles. In response to UV irradiation, CHD1
is recruited to nucleosome cores and depletion experiments
with small interfering RNA (siRNA) demonstrated that
this damage-dependent involvement of CHD1 relies on the
prior recognition of lesion sites by XPC protein. The im-
pact of CHD1 on the GGR pathway was analyzed by in
situ immunofluorescence analyses of subnuclear UV lesion
spots (generated by irradiation through micropore filters).
This approach revealed that XPC protein accumulates at
lesion sites even in the absence of CHD1, whereas the re-
cruitment of TFIIH subunits is reduced, indicating that
CHD1 promotes the transition between XPC bound to nu-
cleosomes and the TFIIH complex (140). Whether CHD1
displaces the nucleosomes while facilitating this GGR tran-
sition is not known, but exactly this mechanism has been
proposed for CHD1 during transcription initiation (141).
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Figure 2. Interaction of XPC protein with histone H3. The domain structure of human XPC is shown with the proposed histone-interacting regions
XPC1–324 and XPC513–940 (49) and the histone-interacting fragment XPC607–766 containing the -turn motif (134). TGD, transglutaminase-like domain;
BHD, -hairpin domains. This initiator of GGR activity emerged as a ‘reader’ of histone methylation marks.
In this early transcription stage, CHD1 associates with the
most promoter-proximal nucleosome of active genes and
evicts this nucleosome to allow for promoter escape by
RNA Pol II. In the absence of CHD1, RNA Pol II re-
mains sequestered on this promoter-proximal nucleosome.
By analogy, in the absence of CHD1, XPC protein becomes
sequestered on lesion sites on nucleosomes, without being
able to give way to the follow-up step involving nucleosome
eviction and TFIIH recruitment. Consequently, the deple-
tion of CHD1 slows down CPD excision (but not the exci-
sion of 6–4PPs) and sensitizes cells to UV-induced cytotox-
icity. The observation that a dynamic interaction between
XPC, CHD1 and TFIIH takes place on nucleosome core
particles strengthens the notion that chromatin is not simply
an impediment to CPD recognition, but acts as a structural
scaffold facilitating damage recognition and GGR transi-
tions (140).
The second example of a chromatin remodeler involved
in downstream GGR reactions is BRG1 (Brahma-Related
Gene 1), which constitutes the catalytic ATPase sub-
unit of the SWI/SNF (SWItching defective/Sucrose Non-
Fermenting) complex, implicated in chromatin relaxation
occurring after UV irradiation (142). The literature of-
fers conflicting reports as to the precise involvement of
SWI/SNF and its BRG1 subunit in the GGR pathway.
Zhang et al. (143) found by immunofluorescence that BRG1
is recruited to spots of UV damage and that small hair-
pin RNA (shRNA)-mediated depletions of BRG1 reduce
XPC accumulation in these damaged sites. An interaction
between BRG1 and XPC was detected by Zhao et al. (142),
but their siRNA-mediated depletion experiments indicated
that the damage-dependent recruitment of BRG1 requires
the prior recognition of lesion sites by XPC protein. This
mode of SWI/SNF recruitment is consistent with the pre-
viously described interactions between SWI/SNF and the
Rad4-Rad23 complex, which is the yeast homolog of hu-
man XPC-RAD23B (135). Next, Zhao et al.monitored the
impact of a BRG1 depletion on the recruitment of up- and
downstream GGR factors to UV lesion spots. They ob-
served that, in the absence of BRG1, the accumulation of
DDB2, XPC and XPB (a subunit of the TFIIH complex)
to lesion sites is unaffected whereas the recruitment of the
more downstream factors XPG and PCNA is reduced. As
was observed in CHD1-depleted cells, the lack of BRG1 in-
hibits the excision of CPDs but not the excision of 6–4PPs
(142,143). Based on these results, it can be concluded that
BRG1 stimulates the repair of CPDs by supporting later
stages of the GGR reaction, again suggesting that part of
the GGR pathway in response to CPDs is executed on a
nucleosome scaffold.
PRIMING OF THE NUCLEOSOME SCAFFOLD BY HI-
STONE METHYLTRANSFERASES
A breakthrough in our understanding of GGR activity in
chromatin came from the discovery of a new layer of reg-
ulation by lysine methyltransferases (KMTs), which use S-
adenosylmethionine to add methyl groups to lysines of hi-
stones. Each of the core histones are folded in a globu-
lar core domain flanked by flexible tails, all presenting ly-
sine residues that, by virtue of their positive charge, in-
teract electrostatically with the negatively charged DNA
backbone. These lysines are the target of posttranslational
modifications including acetylation and methylation (144–
148). By acetylation, the positive charge is masked, which
weakens the electrostatic histone-DNA interactions, thus
relaxing chromatin and exposing the double helix to DNA-
binding proteins (50,149). Instead, lysine methylation does
not change the histone charge but methylated side chains
provide hydrophobic docking sites for downstream ‘reader’
proteins that induce condensation or relaxation of nucleo-
some arrays (146,149,150). The two modifications (acety-
lation and methylation) cannot occur simultaneously on
the same lysine. Conversely, each lysine can accept up to
three methyl groups, generating different degrees of methy-
lation: mono- (me1), di- (me2) or trimethylated (me3). Dis-
tinctive histone modification patterns, for example di- or
trimethylated H3K4, H3K36 and H3K79, or monomethy-
lated H4K20, have been associated with the fluid chro-
matin of expressed genes. Instead, trimethylated H3K9,
H3K27 andH4K20 correlate with the condensed chromatin
of silenced genes. The first hint that histone methylation
may regulate GGR activity came from the discovery in D.
melanogaster that, after UV radiation, there is a decrease of
H3K9me3 in the polytene chromosomes of salivary glands.
This demethylation reaction is triggered by Dmp53 (the D.
melanogaster p53 homolog), which induces expression of
KDM4B (lysine demethylase 4B) that, in turn, demethylates
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H3K9me3. Larvae deficient inKDM4B activity displayUV
hypersensitivity and reduced CPD excision (151). This ef-
fect of a demethylase suggests that an adjustment of histone
methylation may favor GGR activity in the chromatin con-
text.
KMTs responsible for the de novo deposition of methy-
lation marks have been categorized into two evolutionary
conserved groups depending on whether their catalytic cen-
ter displays a seven--strand fold or a SETmotif (Figure 3).
The term ‘seven--strand’ describes awidespreadmethylase
domain that consists of seven -sheets (152). The SET mo-
tif has been named after the Drosophila genes Su(var)3–
9, Enhancer-of-zeste and Trithorax (150,153,154) and the
paradigm of SETD7, a prototypical KMT, demonstrates
that the lysine methylation activity is not necessarily re-
stricted to histones as this posttranslational modification
regulates the stability and function of a much wider range
of proteins (155). At least three lines of evidence support the
conclusion that histone KMTs drive the recognition of UV
lesions at distinct stages of the GGR pathway.
Roles of DOT1L in the UV damage response
The seven--strand methylases DOT1 (Disruptor Of
Telomeric silencing 1) in lower eukaryotes and DOT1L
(DOT1-Like, also known as KMT4) in mammals are solely
responsible for the mono-, di- and trimethylation of the ly-
sine 79 residue of histone H3 (156,157). Of note, the ubiqui-
tination of H2B at lysine 123 in yeast and lysine 120 in hu-
mans precedes H3K79 methylation and these modifications
lie in close proximity within nucleosomes (158–161). It has
been proposed that methylated H3K79, located in the his-
tone globular domain, is not accessible under unchallenged
conditions but becomes exposed when the chromatin struc-
ture is altered for example after DNA damage induction
(162).
The DOT1 gene was originally identified in a ge-
netic screen in the yeast Saccharomyces cerevisiae because,
when over-expressed, the DOT1 enzyme activates genes
mapping to heterochromatic regions of telomeres (163).
DOT1/DOT1L-mediated histone methylation has been as-
sociated with open chromatin during transcription (164–
169) and, in many organisms, a defect in this histone methy-
lation reaction reduces the survival after genotoxic attack,
pinpointing to a function of DOT1/DOT1L in DNA dam-
age responses (158,162,168,170,171). The methylation of
H3K79 by DOT1 is also part of the UV radiation response
in S. cerevisiae (172,173) and in the amoeba Dictyostelium
discoideum (174). Based on the finding thatDOT1-mediated
methylation of H3K79 stimulates GGR activity in yeast,
Tatum and Li (175) proposed that this particular histone
mark may provide a docking site for the GGR complex
in chromatin. DOT1L–/– mouse embryos grow slowly and
die before completing their development (176). Addition-
ally, DOT1L plays an important role inmaintaining normal
erythropoiesis in adults (156,177,178). The human DOT1L
gene is frequently mutated or deleted in melanoma and
many of the detected missense mutations display the UV
signature, i.e. consist of C to T transitions at di-pyrimidine
sites as well as tandem CC to TT transitions (179). How-
ever, the role of DOT1L in the mammalian UV radiation
response remains unclear.
As observed in lower eukaryotes, the absence of DOT1L
in mammalian cells confers UV hypersensitivity. Ok-
senych et al. (180) found in mouse embryonic fibroblasts
that DOT1L supports transcription re-initiation following
DNA damage excision, but without influencing GGR or
TCR activity. These authors used fluorescence-based pro-
tein dynamics studies to show that DOT1L promotes the
binding of RNA Pol II to chromatin during the recov-
ery from UV irradiation. Concomitant ChIP studies indi-
cated that, to re-initiate transcription after UV irradiation,
DOT1L installs a transcription-permissive promoter struc-
ture characterized by H3K79me2 and acetylated histone
H4, accompanied by a low level of the heterochromatin
markH3K9me2, which altogether facilitate the recruitment
of transcription factors driving RNA Pol II. This role in the
reactivation of transcription is reminiscent of the function
of the histone chaperones FACT and HIRA, which are also
dispensable for DNA repair but support transcription re-
covery after exposure to UV light (41,47).
Similarly, Zhu et al. (179) reported that an shRNA-
mediated depletion of DOT1L in primary human
melanocytes as well as loss-of-function DOT1L mu-
tations in melanoma cells impart UV hypersensitivity.
These authors monitored the excision of UV lesions and
found that a deficiency of this enzyme (resulting from the
shRNA-mediated depletion, its inactivation by loss-of-
function mutations or a CRISPR–Cas9-engineered gene
deletion) reduces the excision of both CPDs and 6–4PPs in
melanocytes or melanoma cells. A caveat in these findings
is that Zhu and colleagues observed an unusually fast exci-
sion with half-lives in the range of 2 h for CPDs and less
than 1 h for 6–4PPs. With exceptions (181), other reports
indicate that CPDs are removed from human cells with a
longer half-life of ∼24 h (182). A possible explanation of
the observed short half-lives is the relatively low UV dose
yielding less CPDs and 6–4PPs and, of course, it is possible
that melanocytes display an extraordinary UV lesion repair
rate considering their physiologic role in protecting the skin
from UV light. Nevertheless, it would have been helpful if
Zhu et al. validated the excision assay with control cells
lacking a core repair factor like for example XPA or XPC,
to demonstrate that the observed loss of UV photoprod-
ucts is indeed due to NER activity. On the other hand,
the same authors elaborated on the docking hypothesis
formulated above and showed by immunofluorescence
and chromatin fractionation that DOT1L promotes the
recruitment of XPC protein and downstream factors, but
not the recruitment of the upstream DDB2 subunit, to UV
lesion sites. Intriguingly, there is no extra UV-dependent
recruitment of DOT1L to chromatin in addition to its
constitutive chromatin occupancy. Accordingly, UV irradi-
ation does not increase the degree of H3K79 methylation.
By immunoprecipitation, it was shown that XPC protein
locates to chromatin complexes together with DOT1L
and H3K79me2 (an enzymatic product of DOT1L). In
line with a role of this histone methylation in the GGR
function, conditional-null mice with a DOT1L deletion
in melanocytes provide a very efficient cancer model with
melanoma being induced in nearly 50% of animals by 10
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Figure 3. Overview of histone KMTs stimulating the GGR reaction in response to UV damage. DOT1L is the only known seven--strand methylase
able to methylate lysine residues. Its catalytic domain, containing the seven--strand fold, is flanked by a ubiquitin-interacting motif (UIM) mediating
its binding to ubiquitinated H2B (152,225,226). The lysine-rich region also participates in the interaction with ubiquitinated H2B and contributes to
H3K79 methylation (227). ASH1L and NSD2 are members of a large family of SET-domain methyltransferases (146). The SET domain flanked by AWS
(AssociatedWith SET) forms the catalytic site. The post-SET motif displays a flexible auto-inhibitory loop (188–190). Further domains are the ‘AT hooks’
(putative DNA-binding motifs), BRD (a BRomoDomain interacting with acetylated histones), PHD (Plant HomeoDomain for the binding to methylated
histones), BAH (a Bromo-Associated Homology domain for the binding to methylated histones and other proteins), PWWP (Pro-Trp-Trp-Pro domain
for the binding to methylated histones) and an HMG box (for High Mobility Group, shown to interact with the DNA binding domain of the androgen
receptor) (146,152,228,229). The FxLP motif in ASH1L mediates interactions with MRG15, a chromodomain protein stimulating ASH1L activity by
releasing its auto-inhibitory loop.
weeks after UV irradiation (179). Although the partici-
pation of a constitutive H3K79 methylation in the UV
damage response is clearly established, the impact of this
histone mark is not fully understood but may reside in its
capacity to attract downstream ‘reader’ proteins.
ASH1L as a matchmaker during the DDB2 to XPC handoff
at UV lesions
The histone methyltransferase ASH1 (Absent, Small or
Homeotic discs 1) was identified in D. melanogaster as a
member of the trithorax group that stimulates transcrip-
tion by competing with the Polycomb silencing system
and thereby regulates developmental Hox genes (183). An
ASH1 deficiency causes homeotic transformations like an-
tenna to leg, genitalia to leg or one thoracic segment to
another (184–187). Mammalian ASH1L (ASH1-like, also
known as KMT2H) is a SET-domain protein with histone
H3 methyltransferase activity (Figure 3). The catalytic re-
gion comprises a core SET domain and a shell of flanking
regulatory domains, including the post-SET domain form-
ing an auto-inhibitory loop (188–190), but the exact lysine
target of this enzyme is still debated. Several groups re-
ported that ASH1L generates H3K36me2 (188,191–194),
whereas others identified H3K4 as the methylation target
(195,196). ASH1L is essential in mice (197) and hypomor-
phic mutants result in malformations or dysfunctions af-
fecting the axial skeleton and the central nervous system
(198,199). The ASH1L activity is also important for fer-
tility (200), hematopoiesis and organ function in adults
(196,201). Accordingly, ASH1L is expressed in many tis-
sues (195,202). A role of ASH1L in the adult skin of mice
is demonstrated by a mutation that causes keratinocyte hy-
perplasia, impaired epidermal stratification and defective
wound healing (203). Overexpression of ASH1L is recur-
rent in breast cancer and cancer-associated ASH1L muta-
tions have been identified in melanoma, breast, prostate,
colon, liver and oesophageal cancer (204–207).
Balbo Pogliano et al. (134) identified ASH1L as an
accessory GGR player driving the substrate handover
from DDB2 to XPC protein. Biochemical fractionation re-
vealed that, like DDB2 and XPC, ASH1L associates with
chromatin following UV radiation. Depletion experiments
showed that the DDB2 lesion receptor, independently of
CRL4 ubiquitin ligase activity, is responsible for an ad-
ditional recruitment of ASH1L to the chromatin of UV-
irradiated cells over the constitutive presence of this methyl-
transferase in the chromatin of unchallenged cells. Immuno-
precipitation of DDB2 from cell extracts or solubilized
chromatin results in ASH1L co-precipitation, indicating
that an interaction occurs between these two factors such
that DDB2 mediates the relocation of ASH1L to UV le-
sion sites. The down regulation ofASH1Lmarkedly reduces
CPD excision in HeLa and U2OS cells but has no effect
on the excision of 6-4PPs. This dampened CPD excision
in ASH1L-depleted cells translates to lower repair patch
synthesis measured after a 2-h recovery after UV irradia-
tion, i.e. when most 6–4PPs have been removed. The role
of ASH1L in GGR activity is confirmed by the observa-
tion that its down regulation confers UV hypersensitivity.
Conversely, ASH1L is not involved in the TCR pathway
because transcription recovery after UV radiation remains
unaffected in ASH1L-depleted cells. In view of the finding
that ASH1L stimulates GG-NER but not TC-NER activ-
ity, it was next demonstrated that this KMT does not neg-
atively regulate the expression of XPC and DDB2, which
are solely required for the GGR pathway (134). To under-
stand howASH1L regulates GGRactivity, U2OS cells were
UV-irradiated through filters with 3-m pores to generate
‘small’ spots of UV lesions. After 2-h incubations to allow
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for repair of 6–4PPs, cells were irradiated through 5-m
pores to induce ‘big’ spots of UV lesions. Following another
15-min incubation, the cells were analyzed for XPC relo-
cations. As expected, XPC protein in control cells is able
to engage with not yet processed CPDs in small spots as
well as with newly formed UV lesions, including 6–4PPs,
in big spots. Upon ASH1L depletion, however, XPC is al-
most completely relocated to the big spots, indicating that
in the absence of ASH1L the XPC protein is not able to sta-
bly interact with CPD sites and, as a consequence, readily
moves to 6–4PPs in the newly formed big spots. This XPC
protein dynamics suggests that, presumably by methylating
histones, ASH1L is needed to generate a docking site for
XPC protein in the proximity to CPD sites. This role in se-
curing a stable XPC positioning was confirmed biochemi-
cally by monitoring the amount of this protein associated
with the chromatin of UV irradiated cells. Additionally, in
the absence of ASH1L, XPC protein is impaired in its abil-
ity to recruit the lesion verifier XPD, a subunit of the TFIIH
complex. These findings are in line with the hypothesis that
ASH1L is required to regulate the handoff between DDB2
and XPC, such that the latter is positioned in a robust as-
sociation with CPD sites that allows for the TFIIH recruit-
ment. It remains to be seen what is the critical methylation
target in the GGR pathway and how ASH1L could facil-
itate the ‘hopping’ of XPC towards CPD lesions (see sec-
tion on ‘Mammalian coreNER reaction’ above) in the chro-
matin context.
NSD2 as an auxiliary factor promoting the recruitment of
XPA to damaged sites
The histone methyltransferase NSD2 (Nuclear receptor-
binding SET Domain 2; also known as MMSET for Mul-
tiple Myeloma SET or WHSC1 for Wolf-Hirschhorn Syn-
drome Candidate 1) was first identified by its frequent re-
arrangement with the immunoglobulin locus in multiple
myeloma patients (208,209) and, independently, by its role
in the Wolf-Hirschhorn malformation syndrome (210,211).
Amplifications, gain-of-function mutations or transloca-
tions of NSD2 are linked to numerous types of cancer
(212,213). Mice with homozygous deletions of this gene
do not survive longer than 10 days after birth. Indeed, the
NSD2 methyltransferase regulates crucial developmental
genes including Sall1, Sall4 or Nanog (214). NSD2 is addi-
tionally involved in the repair of DSBs and antibody class
switching recombination (215,216). Moreover, NSD2 inter-
acts with HIRA and like this chaperone is required for the
deposition of the H3.3 histone variant (217).
Elaborating on their previous finding that the endori-
bonuclease Dicer associates with chromatin and thereby
stimulates DNA repair patch synthesis in UV-irradiated
cells, Chitale and Richly (218,219) reported a mechanism
by which Dicer, independently of its ribonuclease activ-
ity, recruits the histone methyltransferase NSD2 to UV le-
sion sites. By immunofluorescence, these authors observed
that NSD2 relocates to intranuclear spots of UV damage
where it generates the histone mark H4K20me2. Although
shRNA experiments indicate that NSD2 activity at UV le-
sion sites depends on DDB2 but is not affected by the de-
pletion of XPC protein, an indispensable GGR core factor,
the authors concluded that NSD2 acts by promoting GGR
activity. In support of this view, Chitale andRichly reported
that the knockdown of NSD2 reduces cell survival after UV
irradiation and also diminishes the synthesis of DNA repair
patches in UV lesion spots. Following NSD2 depletion, the
excision of CPDs was indistinguishable from that in con-
trol cells during the first 24 h after UV irradiation, but then
the rate of CPD excision was lower in NSD2-depleted cells
than in controls between 24 and 48 h after UV irradiation.
Next, the impact on various GGR factors was tested and
the authors found that NSD2 stimulates the recruitment
of XPA protein to intranuclear UV lesion spots. They de-
scribe a scenario in which DDB2 mediates the transloca-
tion of NSD2 to UV lesions by a multiprotein mechanism
that starts with H2A ubiquitination and recruitment of the
ubiquitin-binding protein ZRF1 (Zuotin-Related Factor 1),
which interacts with Dicer. In turn, Dicer provides an inter-
action partner for NSD2, resulting in histone H4 methy-
lation to generate H4K20me2. The authors further argue
that di-methylation of histoneH4 generates a docking point
for 53BP1, which is also a ‘reader’ of the H4K20me2 mark
and, through interactions with RPA, this multiprotein net-
work promotes the recruitment of XPA protein to lesion
sites (219). The relevance of this protein network for the
GGR process is not yet conclusively demonstrated, par-
ticularly in view of the finding that the assembly of this
chromatin-associated complex, and the consequent recruit-
ment of XPA, is triggered by DDB2 without participa-
tion of XPC protein, which is the indispensable initiator of
GGR activity. Such a recruitment of XPA in the absence of
XPC is generally not observed (66). Another caveat is that
the purported contribution of NSD2 in H4K20 methyla-
tion, to promote 53BP1 recruitment to sites of DNA dam-
age (215), remained controversial (220). Other KMTs have
since then been implicated in this reaction (221,222). On the
other hand, NSD2 is also capable of methylating H3K36
(223) and may therefore act in concert with DOT1L and
ASH1L to modify histone H3 in response to UV radiation.
In any case, the potential contribution of NSD2 in modu-
lating the histone code at UV lesions confirms once more
that the DNA substrate remains at least partially ‘chroma-
tinized’ and reinforces the hypothesis thatKMTs are needed
to carry out the GGR process in the nucleosome landscape
of chromatin.
CONCLUSIONS
The GGR machine constitutes a major caretaker of the
human genome, safeguarding cellular homeostasis against
endogenous and exogenous genotoxic insults. For exam-
ple, NER mitigates the negative effects of the UV radia-
tion of sunlight including sunburns, skin photoaging and
cutaneous cancer. The same DNA repair process is respon-
sible for the excision of bulky DNA adducts elicited by to-
bacco smoke, food carcinogens and crosslinking drugs. The
GGR pathway is also the sole DNA repair system avail-
able for the excision of bulky lesions resulting from endoge-
nous metabolic byproducts like, in particular, cyclopurine
adducts generated by reactive oxygen species (25). In view
of the pathophysiologic consequences of persistently accu-
mulating DNA damage, this excision repair response is es-
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sential to prevent chronic diseases like cancer and to pro-
tect from neurodegeneration and other debilitating traits
of aging, which now belong to the most significant public
health problems in Western societies. It is, therefore, impor-
tant to understand the emerging role of KMTs like DOT1L,
ASH1L and NSD2 in regulating the efficiency by which
the GGR machine removes bulky DNA adducts. An out-
standing question is to determine whether the relevant his-
tone modifications are constitutive (as currently suggested
for DOT1L) or induced around the lesions (as suggested
for ASH1L and NSD2). It remains to be determined what
are the critical methylation targets of these KMTs during
the GGR process and how their interplay stimulates DNA
damage recognition and downstream GGR reactions. Be-
sides, the chromatin context should be taken into account
and more particularly the presence of histones variants. For
example, histone variantH3.3 is more easily foundmodified
by DOT1L than the canonical histone H3.1 (224), which
may give rise to combinatorial, possibly synergistic effects
of histone variants and histone methylation in modulating
GGR efficiency. Knowledge of the molecular mechanism
by which KMTs fine-tune GGR activity, and thereby mit-
igate DNA damage accumulation, cell cycle checkpoints,
apoptosis and mutagenesis, will pave the way to the iden-
tification of new drug targets and the development of novel
therapeutic approaches for the management of cancer and
other chronic conditions. We would envision, for example,
a strategy where a specific KMT deficiency might be coun-
teracted or at least mitigated through the maintenance of
minimal methylation levels by deactivating appropriate ly-
sine demethylases with selective inhibitors.
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84. Mathieu,N., Kaczmarek,N., Rüthemann,P., Luch,A. and Naegeli,H.
(2013) DNA quality control by a lesion sensor pocket of the
xeroderma pigmentosum group D helicase subunit of TFIIH. Curr.
Biol., 23, 204–212.
85. Coin,F., Oksenych,V., Mocquet,V., Groh,S., Blattner,C. and
Egly,J.M. (2008) Nucleotide excision repair driven by the
dissociation of CAK from TFIIH.Mol. Cell, 31, 9–20.
86. Kokic,G., Chernev,A., Tegunov,D., Dienemann,C., Urlaub,H. and
Cramer,P. (2019) Structural basis of TFIIH activation for nucleotide
excision repair. Nat. Commun., 10, 2885.
87. Evans,E., Fellows,J., Coffer,A. and Wood,R.D. (1997) Open
complex formation around a lesion during nucleotide excision repair
provides a structure for cleavage by human XPG protein. EMBO J.,
16, 625–638.
88. Wakasugi,M. and Sancar,A. (1998) Assembly, subunit composition,
and footprint of human DNA repair excision nuclease. Proc. Natl.
Acad. Sci. U.S.A., 95, 6669–6674.
89. Missura,M., Buterin,T., Hindges,R., Hübscher,U., Kaspárková,J.,
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Rapić-Otrin,V. (2012) Monoubiquitinated histone H2A destabilizes
photolesion-containing nucleosomes with concomitant release of
UV-damaged DNA-binding protein E3 ligase. J. Biol. Chem., 287,
12036–12049.
120. Luijsterburg,M.S., Lindh,M., Acs,K., Vrouwe,M.G., Pines,A., van
Attikum,H., Mullenders,L.H. and Dantuma,N.P. (2012) DDB2
promotes chromatin decondensation at UV-induced DNA damage.
J. Cell Biol., 197, 267–281.
121. Robu,M., Shah,R.G., Purohit,N.K., Zhou,P., Naegeli,H. and
Shah,G.M. (2017) Poly(ADP-ribose) polymerase 1 escorts XPC to
UV-induced DNA lesions during nucleotide excision repair. Proc.
Natl. Acad. Sci. U.S.A., 114, E6847–E6856.
122. Brand,M., Moggs,J.G., Oulad-Abdelghani,M., Lejeune,F.,
Dilworth,F.J., Stevenin,J., Almouzni,G. and Tora,L. (2001)
UV-damaged DNA-binding protein in the TFTC complex links
DNA damage recognition to nucleosome acetylation. EMBO J., 20,
3187–3196.
123. Datta,A., Bagchi,S., Nag,A., Shiyanov,P., Adami,G.R., Yoon,T. and
Raychaudhuri,P. (2001) The p48 subunit of the damaged-DNA
binding protein DDB associates with the CBP/p300 family of
histone acetyltransferase.Mutat. Res. Repair, 486, 89–97.
124. Cazzalini,O., Perucca,P., Savio,M., Necchi,D., Bianchi,L.,
Stivala,L.A., Ducommun,B., Scovassi,A.I. and Prosperi,E. (2008)
Interaction of p21 CDKN1A with PCNA regulates the histone
acetyltransferase activity of p300 in nucleotide excision repair.
Nucleic Acids Res., 36, 1713–1722.
125. Guo,R., Chen,J., Mitchell,D.L. and Johnson,D.G. (2011) GCN5
and E2F1 stimulate nucleotide excision repair by promoting H3K9
acetylation at sites of damage. Nucleic Acids Res., 39, 1390–1397.
126. Horikoshi,N., Tachiwana,H., Kagawa,W., Osakabe,A.,
Matsumoto,S., Iwai,S., Sugasawa,K. and Kurumizaka,H. (2016)
Crystal structure of the nucleosome containing ultraviolet
light-induced cyclobutane pyrimidine dimer. Biochem. Biophys. Res.
Commun., 471, 117–122.
127. Cai,Y., Fu,I., Geacintov,N.E., Zhang,Y. and Broyde,S. (2018)
Synergistic effects of H3 and H4 nucleosome tails on structure and
dynamics of a lesion-containing DNA: Binding of a displaced lesion
partner base to the H3 tail for GG-NER recognition. DNA Repair
(Amst)., 65, 73–78.
128. Otrin,V.R., McLenigan,M., Takao,M., Levine,A.S. and Protic,M.
(1997) Translocation of a UV-damaged DNA binding protein into a
tight association with chromatin after treatment of mammalian cells
with UV light. J. Cell Sci., 110, 1159–1168.
129. Groisman,R., Polanowska,J., Kuraoka,I., Sawada,J., Saijo,M.,
Drapkin,R., Kisselev,A.F., Tanaka,K. and Nakatani,Y. (2003) The
ubiquitin ligase activity in the DDB2 and CSA complexes is
differentially regulated by the COP9 signalosome in response to
DNA damage. Cell, 113, 357–367.
130. Yasuda,T., Sugasawa,K., Shimizu,Y., Iwai,S., Shiomi,T. and
Hanaoka,F. (2005) Nucleosomal structure of undamaged DNA
regions suppresses the non-specific DNA binding of the XPC
complex. DNA Repair (Amst)., 4, 389–395.
131. Hoogstraten,D., Bergink,S., Ng,J.M.Y., M Verbiest,V.H.,
Luijsterburg,M.S., Geverts,B., Raams,A., Dinant,C.,
Hoeijmakers,J.H., Vermeulen,W. et al. (2008) Versatile DNA
damage detection by the global genome nucleotide excision repair
protein XPC. J. Cell Sci., 121, 2850–2859.
132. Solimando,L., Luijsterburg,M.S., Vecchio,L., Vermeulen,W., van
Driel,R. and Fakan,S. (2009) Spatial organization of nucleotide
excision repair proteins after UV-induced DNA damage in the
human cell nucleus. J. Cell Sci., 122, 83–91.
133. Fei,J., Kaczmarek,N., Luch,A., Glas,A., Carell,T. and Naegeli,H.
(2011) Regulation of nucleotide excision repair by UV-DDB:
prioritization of damage recognition to internucleosomal DNA.
PLoS Biol., 9, e1001183.
134. Balbo Pogliano,C., Gatti,M., Rüthemann,P., Garajovà,Z.,
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